Amber Watson

Doctor of Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Biostatistics Hospital-Pharmacy-Insurance

Areas Of Interest

Data, Linked S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid Physician Payment Review Commission Lysatec rtPA Proton Translocating ATPase Complexes Olfactory Grooves Hybrid, Somatic Cell Hydrochloride, Dexrazoxane Synovial Folds Complex, Trapezoid Nuclear Hair Cell, Cochlear Pathogen-Free Organism, Specific Dental Tissue Neoplasms MPS IIIB Diffusion Weighted MRI Emericella Herpesvirus 1 (alpha), Gallid GDF-3 Gray Platelet Syndrome Effectors, Transcription Activator-Like Surface Microspikes, Cell Rupture, Traumatic Cardiac D&C Blue NO. 6 Ozone Hole Technique, Estimation RNA Instability ras Gene Products Pectus Carinatums, Chondrogladiolar Transaminase, Alanine Protozoan DNA Antiglobulin Augmented Lymphocytotoxicity Test Monocyte Chemotactic Proteins Isotopes, Mercury Smoking Pipes Oncology Pain gamma Globins CSF-M Xiakucaos Lujo virus Besnier-Boeck Disease

Professional Narrative

Dr. Amber Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2006
Assistant Professor, Mayo Clinic 2011

Education

Doctor of medicine, Perelman School of Medicine 2005
Bachelor of science in nursing, Perelman School of Medicine 1997

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :